Skip to content
The Nexus
BUSINESSAug 5 · 09:15 UTCBLOOMBERG

Wegovy Profitability Will Keep Improving, Novo CEO Says

Novo Nordisk Chief Executive Officer Mike Doustdar states that the profitability of its weight-loss pill Wegovy is 'decent' and will improve, citing expansion into more markets as evidence. He emphasizes that continued market launches support this outlook.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Mike DoustdarpersonNovo NordiskorganizationWegovytopicBloomberg Televisionorganization
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting